Early Management of Newly Diagnosed Rheumatoid Arthritis by Canadian Rheumatologists: A National, Multicenter, Retrospective Cohort
Authors:
- Ruben TavaresRTRuben Tavares
- Janet E. PopeJPJanet E. Pope
- Jean-Luc TremblayJTJean-Luc Tremblay
- Carter ThorneCTCarter Thorne
- Vivian P. BykerkVBVivian P. Bykerk
- Juris LazovskisJLJuris Lazovskis
- Kenneth L.N. BlockaKBKenneth L.N. Blocka
- Mary J. BellMBMary J. Bell
- Diane LacailleDLDiane Lacaille
- Carol A. HitchonCHCarol A. Hitchon
- Avril A. FitzgeraldAFAvril A. Fitzgerald
- Wesley K. FidlerWFWesley K. Fidler
Open Access
- 1 September 2011
- journal article
- research article
- Published by The Journal of Rheumatology in The Journal of Rheumatology
- Vol. 38 (11) , 2342-2345
Abstract
Objective.: To describe early rheumatologic management for newly diagnosed rheumatoid arthritis (RA) in Canada.Methods.: A retrospective cohort of 339 randomly selected patients with RA diagnosed from 2001–2003 from 18 rheumatology practices was audited between 2005–2007.Results.: The most frequent initial disease-modifying antirheumatic drugs (DMARD) included hydroxychloroquine (55.5%) and methotrexate (40.1%). Initial therapy with multiple DMARD (15.6%) or single DMARD and corticosteroid combinations (30.7%) was infrequent. Formal assessment measures were noted infrequently, including the Health Assessment Questionnaire (34.6%) and Disease Activity Score for 28 joints (8.9%).Conclusion.: Initial pharmacotherapy is consistent with guidelines from the period. The infrequent reporting of multiple DMARD combinations and formal assessment measures has implications for current clinical management and warrants contemporary reassessment.Keywords
This publication has 10 references indexed in Scilit:
- Current evidence for a strategic approach to the management of rheumatoid arthritis with disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of rheumatoid arthritisAnnals of the Rheumatic Diseases, 2010
- Contemporary patterns of care and disease activity outcome in early rheumatoid arthritis: the ERAN cohortRheumatology, 2008
- American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease‐modifying antirheumatic drugs in rheumatoid arthritisArthritis Care & Research, 2008
- EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)Annals of the Rheumatic Diseases, 2007
- Ensuring high accuracy of data abstracted from patient charts: the use of a standardized medical record as a training toolJournal of Clinical Epidemiology, 2005
- How to diagnose rheumatoid arthritis early: A prediction model for persistent (erosive) arthritisArthritis & Rheumatism, 2002
- Guidelines for the management of rheumatoid arthritis: 2002 UpdateArthritis & Rheumatism, 2002
- Combination therapy in rheumatoid arthritisCurrent Opinion in Rheumatology, 2001
- Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: a randomised trialThe Lancet, 1999
- Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritisThe Lancet, 1997